NCT04788004

Brief Summary

The goals of this study are to provide a scientific understanding of recovery and relapse, as well as to identify novel targets for future relapse prevention interventions.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
733

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Sep 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Sep 2022Jul 2026

First Submitted

Initial submission to the registry

March 3, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 9, 2021

Completed
1.5 years until next milestone

Study Start

First participant enrolled

September 8, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2026

Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

3.9 years

First QC Date

March 3, 2021

Last Update Submit

January 14, 2026

Conditions

Outcome Measures

Primary Outcomes (9)

  • CNDS functioning

    Delay Discounting (DD) task will be administered to assesses the value of delayed reinforcers. Participants make hypothetical choices between amounts of delayed and immediate money at various delays (e.g., 1 day to 25 years)

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  • Psychosocial Functioning- The Psychosocial Functioning Inventory (PFI)

    The Psychosocial Functioning Inventory (PFI) will be used to measure social functioning. The social behavior sub-scale will be calculated from 10 items of the PFI and included items that assess the frequency of problematic social behavior and social interactions in the past 90 days. The psychosocial functioning scale yields a score ranging from 0-100, with higher scores indicating greater impairment.

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  • Psychosocial Functioning- World Health Organization (WHO)-Quality of Life

    WHO-Quality of Life brief assessment (BREF) will be used to measure the four domains of quality of life: (1) physical health; (2) psychological (3) social relationships; and (4) environment (26 items). Each item in the WHOQOL-BREF will be scored with a 5-point Likert scale (three items are reverse scored), and these scores will be used to generate raw scores for each domain, which will be then scaled 0-100, with higher scores indicating greater quality of life.

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  • Psychosocial Functioning- Satisfaction with Life and social Functioning

    Satisfaction with life and social functioning over the past 90 days will be assessed using 4 questions: How happy have you been (1) with life?; (2) with your living situation? and (3) with your relationships? and (4) Did you feel satisfied with leisure, social, and recreational activities? (0 = satisfied/happy; 1 = dissatisfied/unhappy)

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  • Psychosocial Functioning- Career Engagement

    Engagement in proactive career behaviors over time (9 items). Each item in the career engagement measure will be scored with the 5-point Likert-type scale. The average scale scores will range between 1-5 with higher score indicating greater engagement.

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  • Psychosocial Functioning- Addiction Severity

    The Addiction Severity Index (ASI) will be used to assess experiences of serious depression, serious anxiety or tension, and cognitive difficulty (i.e., trouble understanding, concentrating, or remembering) in the past 90 days. All items will be binary indicators, where 0 = employed or symptom not present and 1 = unemployed or symptom present. Items will be examined individually.

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  • Alcohol Use- AUD Status and Severity

    The Diagnostic and Statistical Manual-5 (DSM-5) AUD (last year \& last 3 months) will be used to assess AUD status and severity with mild, moderate, and severe sub-classifications

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  • Alcohol Use- Consumption

    Timeline Follow Back-90 (TLFB-90) will be used to obtains retrospective daily estimates of alcohol consumption in the last 3 month. TLFB can generate a variety of variables that provide more precise and varied information (e.g., pattern, variability, drinking levels) about a person's drinking

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  • Adverse Social and emotional events

    Inventory of Drug Taking Situations (IDTS-8) will be used to assess the frequency of common relapse-inducing events (i.e., negative affect, social pressure, physical discomfort, and drinking-related variables such as temptations, urges, and alcohol cues; 8 items)

    Approximately every 3 months from date of baseline session through study completion, an average of 3 years

Study Arms (10)

Cohort 1

Participants in this group started their recovery process \< 1 year ago

Other: Online survey

Cohort 2

Participants in this group started their recovery process 1 to \<2 years ago

Other: Online survey

Cohort 3

Participants in this group started their recovery process 2 to \<3 years ago

Other: Online survey

Cohort 4

Participants in this group started their recovery process 3 to \<4 years ago

Other: Online survey

Cohort 5

Participants in this group started their recovery process 4 to \<5 years ago

Other: Online survey

Cohort 6

Participants in this group started their recovery process 5 to \<6 years ago

Other: Online survey

Cohort 7

Participants in this group started their recovery process 6 to \<7 years ago

Other: Online survey

Cohort 8

Participants in this group started their recovery process 7 to \<8 years ago

Other: Online survey

Cohort 9

Participants in this group started their recovery process 8 to \<9 years ago

Other: Online survey

Cohort 10

Participants in this group started their recovery process 9 to \<10 years ago

Other: Online survey

Interventions

There are no interventions planned for this study. This is an observational study only.

Cohort 1Cohort 10Cohort 2Cohort 3Cohort 4Cohort 5Cohort 6Cohort 7Cohort 8Cohort 9

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals in recovery from AUD who meets the study inclusion criteria will be recruited from The International Quit \& Recovery Registry (IQRR) (https://quitandrecovery.org). Participants will be recruited from existing or new IQRR registrants; that is, IQRR registrants meeting the inclusion criteria (see above) will be invited to participate. Also, the recruitment of new registrants will use methods designed to reflect the heterogeneity of the recovery population.

You may qualify if:

  • be ≥18 yrs old
  • meet lifetime DSM-5 AUD criteria
  • have a Recovery Initiation Date less than 10 years prior to the time of enrollment
  • be able to read independently
  • be free of legal problems that could limit participation
  • reside in the U.S.
  • anticipate continued Internet access (to ensure ongoing contact and data collection)
  • be a registrant of the International Quit and Recovery Registry (IQRR)

You may not qualify if:

  • Minors will not be included
  • Prisoners will not be included. If participants become incarcerated during this study, they will not be contacted to complete assessments during their incarceration. If the incarcerations ends during the study, they may be contacted to participate in assessments.
  • Adults who are not capable of consenting on their own behalf

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, 24016, United States

Location

MeSH Terms

Conditions

Alcoholism

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Jungmeen Kim-Spoon, PhD

    Virginia Polytechnic Institute and State University

    PRINCIPAL INVESTIGATOR
  • Allison Tegge, PhD

    Virginia Polytechnic Institute and State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 3, 2021

First Posted

March 9, 2021

Study Start

September 8, 2022

Primary Completion (Estimated)

July 20, 2026

Study Completion (Estimated)

July 20, 2026

Last Updated

January 16, 2026

Record last verified: 2026-01

Locations